Advertisement
Advertisement

KRMD

KRMD logo

KORU Medical Systems, Inc. Common Stock (DE)

4.00
USD
-0.17
-3.97%
Sep 22, 15:59 UTC -4
Closed
exchange

After-Market

4.01

+0.02
+0.50%

KORU Medical Systems, Inc. Common Stock (DE) Profile

About

KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J.

Info & Links

CEO

Linda Tharby

Headquarters

100 CORPORATE DRIVE
MAHWAH, NJ 07430, UNITED STATES

Sector

Medical

Auditor

Cherry Bekaert LLP

Share holders

431

Employees

80

KORU Medical Systems, Inc. Common Stock (DE) Statistics

Valuation Measures

Market Capitalization2

185.63M

Enterprise Value

177.84M

Enterprise Value/EBITDA(ttm)

-44.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.58

Price to Book(mrq)

9.82

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

63.15%

Operating Margin(ttm)

-15.09%

Profit Margin(ttm)

-12.78%

Return on Equity(ttm)

-30.43%

Return on Invested Capital(ttm)

-26.28%

Return on Assets(ttm)

-19.41%

Income Statement

Revenue(ttm)

36.85M

Revenue Per Share(ttm)

0.80

Gross Profit(ttm)

23.27M

EBITDA(ttm)3

-3.98M

Net Income Available to Common(ttm)

-4.51M

Diluted EPS(ttm)

-0.11

Share Statistics

Beta (5Y Monthly)

0.52

52-Week Change

48.51%

S&P 500 52-Week Change

17.05%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

46.23M

Dividend Yield

0.00%

Float4

36.64M

% Held by Insiders

20.60%

% Held by Institutions

58.60%

Balance Sheet

Total Cash(mrq)

8.05M

Total Cash Per Share(mrq)

0.17

Total Debt(mrq)

264.10K

Total Debt/Equity(mrq)

1.60%

Current Ratio(mrq)

2.91%

Quick Ratio(mrq)

2.02%

Book Value Per Share(mrq)

0.36

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.02

Free Cash Flow(ytd)

-1.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement